Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China · Delayed Price · Currency is CNY 3.700
0.00 (0.00%)
Jul 30, 2026, 10:40 AM CST
SHE:300194 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 749.51 | 886.62 | 846.31 | 991.84 | 688.53 | 981.13 |
Trading Asset Securities | 170.12 | 150.05 | 30 | 5.05 | 15.21 | 20.86 |
Cash & Short-Term Investments | 919.63 | 1,037 | 876.32 | 996.89 | 703.74 | 1,002 |
Cash Growth | -8.84% | 18.30% | -12.10% | 41.66% | -29.77% | 7.85% |
Accounts Receivable | 204.98 | 228.37 | 255.39 | 359.39 | 433.24 | 393.02 |
Other Receivables | 9.4 | 12.23 | 31.31 | 23.8 | 18.92 | 19.66 |
Receivables | 214.38 | 240.6 | 286.71 | 383.19 | 452.16 | 412.68 |
Inventory | 650.86 | 643.05 | 850.97 | 707.8 | 719.75 | 631.92 |
Other Current Assets | 30.05 | 26.27 | 51.7 | 38.36 | 51.42 | 38.6 |
Total Current Assets | 1,815 | 1,947 | 2,066 | 2,126 | 1,927 | 2,085 |
Property, Plant & Equipment | 1,671 | 1,700 | 1,767 | 1,736 | 1,696 | 1,446 |
Long-Term Investments | 1,183 | 1,320 | 1,216 | 1,183 | 1,072 | 752.43 |
Goodwill | 132.16 | 132.16 | 261.18 | 261.18 | 485.69 | 508.66 |
Other Intangible Assets | 458.74 | 462.17 | 441.2 | 401.71 | 383.81 | 382.37 |
Long-Term Deferred Tax Assets | 79.47 | 76.72 | 60.54 | 65.81 | 101.86 | 49.15 |
Long-Term Deferred Charges | 119.98 | 118.3 | 105.37 | 138.52 | 176.2 | 170.25 |
Other Long-Term Assets | 174.52 | 7.98 | 61.6 | 63.37 | 35.35 | 312.58 |
Total Assets | 5,633 | 5,763 | 5,979 | 5,976 | 5,878 | 5,706 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 256.93 | 274.86 | 436.39 | 379.48 | 385.07 | 289.77 |
Accrued Expenses | 12.38 | 76.33 | 116.73 | 225.43 | 253.93 | 232.76 |
Short-Term Debt | 211.51 | 355.42 | 333.32 | 349.11 | 406.34 | 642.15 |
Current Portion of Long-Term Debt | - | 38.35 | 177.32 | 54.06 | 2.51 | - |
Current Portion of Leases | 185.09 | 0.5 | 1.11 | 0.98 | 0.58 | - |
Current Income Taxes Payable | 23.01 | 6.54 | 4.46 | 15.52 | 6.62 | 9 |
Current Unearned Revenue | 33.32 | 22.44 | 54.09 | 51.25 | 61.96 | 57.15 |
Other Current Liabilities | 85.44 | 65.14 | 103.58 | 119.22 | 170.04 | 57.66 |
Total Current Liabilities | 807.67 | 839.57 | 1,227 | 1,195 | 1,287 | 1,288 |
Long-Term Debt | 250.62 | 406 | 193.54 | 487.14 | 303.7 | 263.88 |
Long-Term Leases | 0.14 | 0.16 | 0.49 | 1.57 | 1.06 | - |
Long-Term Unearned Revenue | 105.55 | 108.48 | 109.91 | 92.36 | 98.06 | 75.03 |
Long-Term Deferred Tax Liabilities | 43.79 | 43.71 | 49.5 | 51.09 | 64.35 | 35.92 |
Other Long-Term Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 177.27 | 177.27 |
Total Liabilities | 1,208 | 1,398 | 1,580 | 1,827 | 1,932 | 1,841 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 |
Additional Paid-In Capital | 2,237 | 2,237 | 2,237 | 2,237 | 2,227 | 2,227 |
Retained Earnings | 1,001 | 945.98 | 952.26 | 731.91 | 559.53 | 354.92 |
Comprehensive Income & Other | -3.96 | -9.09 | 16.74 | -13.98 | -31.58 | -37.96 |
Total Common Equity | 4,424 | 4,364 | 4,396 | 4,145 | 3,945 | 3,734 |
Minority Interest | 1.6 | 1.74 | 2.25 | 3.92 | 1.38 | 131.75 |
Shareholders' Equity | 4,425 | 4,366 | 4,398 | 4,149 | 3,946 | 3,866 |
Total Liabilities & Equity | 5,633 | 5,763 | 5,979 | 5,976 | 5,878 | 5,706 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 647.36 | 800.42 | 705.78 | 892.86 | 714.2 | 906.03 |
Net Cash (Debt) | 272.28 | 236.24 | 170.54 | 104.03 | -10.45 | 95.96 |
Net Cash Growth | 109.00% | 38.52% | 63.93% | - | - | -68.79% |
Net Cash Per Share | 0.21 | 0.18 | 0.15 | 0.09 | -0.01 | 0.08 |
Filing Date Shares Outstanding | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 |
Total Common Shares Outstanding | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 |
Working Capital | 1,007 | 1,107 | 838.7 | 931.19 | 640.01 | 796.7 |
Book Value Per Share | 3.72 | 3.67 | 3.69 | 3.48 | 3.32 | 3.14 |
Tangible Book Value | 3,833 | 3,769 | 3,693 | 3,482 | 3,076 | 2,843 |
Tangible Book Value Per Share | 3.22 | 3.17 | 3.10 | 2.93 | 2.59 | 2.39 |
Buildings | - | 1,266 | 1,249 | 1,191 | 875.88 | 871.16 |
Machinery | - | 1,776 | 1,775 | 1,615 | 1,347 | 1,225 |
Construction In Progress | - | 126.93 | 114.23 | 155.84 | 695.25 | 441.2 |